home About Us People Portfolio News Contact Us Fund I Investor Login » Fund II Investor Login »


Tag: 2013

Nov18TriVascular Secures $40 Million in Equity Financing »

November 18, 2013—TriVascular, Inc. (Santa Rosa, CA) announced the close of a $40 million Series E Preferred Stock equity financing that the company will use to support worldwide commercialization, product development,...

Read More »

Nov18Solta Medical Secures $40 Million Financing »

HAYWARD, Calif., Nov. 18, 2013 -- Solta Medical, Inc. (NASDAQ: SLTM), a global leader in the medical aesthetics market, today announced that it has closed a structured debt financing with Capital...

Read More »

Nov4Exagen Diagnostics and Capital Royalty Close Financing Transaction »

Albuquerque, New Mexico – November 4, 2013 – Exagen Diagnostics, Inc. and Capital Royalty Partners II, L.P. announced that they have closed a senior secured loan for up to $25...

Read More »

Sep23RainDance Technologies Secures $35 Million in Financing from Capital Royalty Partners »

--- Financing Proceeds to Accelerate Growth and Market Expansion in Leading Digital PCR and Next-Gen Sequencing Products ---   BILLERICA, Mass – September 23, 2013 – RainDance Technologies, Inc., an innovative...

Read More »

Jun14Valeritas Closes $100 Million Financing »

-- Valeritas Expanding V-Go US Commercial Operations –   BRIDGEWATER, N.J., June 4, 2013 (PR NEWSWIRE) – Valeritas, makers of the V-Go® insulin delivery device, today announced that they...

Read More »

May8Good Start Genetics Announces $28 Million Financing From Capital Royalty »

CAMBRIDGE, Massachusetts, May 8, 2013 - Good Start Genetics®, Inc., an innovative molecular diagnostics company that has developed the new gold standard in carrier screening, today announced that it...

Read More »

May2Capital Royalty Announces $805 Million Fund Closing for Capital Royalty Partners II »

Total Investable Capital Expected to Exceed $1 Billion Including Debt Financing   HOUSTON, TX   May 2, 2013 -- Capital Royalty L.P., a pioneer in healthcare investing, today announced the final...

Read More »

Feb5TriVascular and Capital Royalty Close Term Loan Facility »

SANTA ROSA, CA, February 5, 2013 – TriVascular, Inc. (“TriVascular” or the “Company”) and Capital Royalty Partners II, L.P. (“Capital Royalty”) announced that they...

Read More »

Jan21TriVascular Receives U.S. FDA Approval for the Ovation Primeā„¢ Abdominal Stent Graft System »

-- Innovative Delivery System Further Enhances Ease of Use --   Santa Rosa, CA, January 21, 2013 – TriVascular, Inc. today announced U.S. Food & Drug Administration (FDA) approval of...

Read More »